QALGX | VIGAX | QALGX / VIGAX | |
Total Expense Ratio | 1.00 | 0.05 | 2,000% |
Annual Report Gross Expense Ratio | 1.13 | 0.05 | 2,260% |
Fund Existence | 20 years | 25 years | - |
Gain YTD | 8.774 | 7.727 | 114% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1500 | 3000 | 50% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.07B | 294B | 1% |
Annual Yield % from dividends | 0.00 | 0.45 | - |
Returns for 1 year | 14.19 | 15.43 | 92% |
Returns for 3 years | 72.75 | 96.41 | 75% |
Returns for 5 years | 54.45 | 115.36 | 47% |
Returns for 10 years | 108.52 | 312.86 | 35% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BFTUX | 64.66 | 1.05 | +1.65% |
Baron Fifth Avenue Growth R6 | |||
PCEKX | 24.55 | 0.14 | +0.57% |
Victory Pioneer Core Equity R6 | |||
PEIJX | 41.73 | 0.19 | +0.46% |
Principal Equity Income J | |||
NIEYX | 18.23 | 0.04 | +0.22% |
BNY Mellon International Equity Y | |||
LYFCX | 11.94 | -0.01 | -0.08% |
AlphaCentric Life Sciences & Hlthcare C |